Display options
Share it on

J Intensive Care. 2017 Sep 25;5:58. doi: 10.1186/s40560-017-0252-x. eCollection 2017.

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?.

Journal of intensive care

Santi Maurizio Raineri, Andrea Cortegiani, Filippo Vitale, Pasquale Iozzo, Antonino Giarratano

Affiliations

  1. Department of Biopathology and Medical Biotechnologies (DIBIMED). Section of Anesthesia, Analgesia, Intensive Care and Emergency. Policlinico P. Giaccone, University of Palermo, Via del vespro 129, 90127 Palermo, Italy.

PMID: 28975031 PMCID: PMC5613326 DOI: 10.1186/s40560-017-0252-x

Abstract

Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of

Keywords: Candida spp.; Invasive candidiasis; Procalcitonin; Sepsis

References

  1. N Engl J Med. 2015 Oct 8;373(15):1445-56 - PubMed
  2. Turk J Anaesthesiol Reanim. 2016 Dec;44(6):276-278 - PubMed
  3. Intensive Care Med. 2006 Oct;32(10 ):1577-83 - PubMed
  4. Intern Emerg Med. 2017 Aug;12 (5):629-635 - PubMed
  5. BMC Anesthesiol. 2014 Feb 21;14 :9 - PubMed
  6. JAMA. 2017 Jan 17;317(3):311-312 - PubMed
  7. Intensive Care Med. 2017 Mar 2;:null - PubMed
  8. Crit Care. 2017 Jul 10;21(1):176 - PubMed
  9. Cochrane Database Syst Rev. 2016 Jan 16;(1):CD004920 - PubMed
  10. J Infect. 2010 Jun;60(6):425-30 - PubMed
  11. J Intensive Care. 2017 Aug 3;5:51 - PubMed

Publication Types